Literature DB >> 29974995

Contrast-enhanced 18F-FDG-PET/CT for Differentiating Tumour and Radionecrosis in Head and Neck Cancer: Our experience in 37 Patients.

Christian M Meerwein1,2, Masashi Nakadate3, Paul Stolzmann2,3, Domenic Vital1,2, Grégoire B Morand1,2, Daniel F Zweifel2,4, Gerhard F Huber2,5, Martin W Huellner2,3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29974995     DOI： 10.1111/coa.13185

Source DB:  PubMed          Journal:  Clin Otolaryngol        ISSN： 1749-4478            Impact factor:   2.597


× No keyword cloud information.
  2 in total

1.  FDG-PET/CT for oral focus assessment in head and neck cancer patients.

Authors:  Dominic Raphael Schwaninger; Martin Hüllner; Dominique Bichsel; Barbara Giacomelli-Hiestand; Nicole Selina Stutzmann; Panagiotis Balermpas; Silvio Valdec; Bernd Stadlinger
Journal:  Clin Oral Investig       Date:  2022-03-07       Impact factor: 3.606

2.  Predictive value of suvmax changes between two sequential post-therapeutic FDG-pet in head and neck squamous cell carcinomas.

Authors:  Thomas M Stadler; Martin W Hüllner; Martina A Broglie; Grégoire B Morand
Journal:  Sci Rep       Date:  2020-10-07       Impact factor: 4.379
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.